Methods for non-invasive prenatal ploidy calling
AssigneeNatera, Inc.
InventorsMatthew Rabinowitz, Allison Ryan, George Gemelos, Milena Banjevic, Zachary Demko
Life of this patent
Estimating the term…
Loading patent…
AssigneeNatera, Inc.
InventorsMatthew Rabinowitz, Allison Ryan, George Gemelos, Milena Banjevic, Zachary Demko
Estimating the term…
Disclosed herein are methods for determining the copy number of a chromosome in a fetus in the context of non-invasive prenatal diagnosis. In an embodiment, the measured genetic data from a sample of genetic material that contains both fetal DNA and maternal DNA is analyzed, along with the genetic data from the biological parents of the fetus, and the copy number of the chromosome of interest is determined. In an embodiment, the maternal serum is measured using a single-nucleotide polymorphism (SNP) microarray, along with parental genomic data, and the determination of the chromosome copy number is used to make clinical decisions pertaining to the fetus.
A method for determining the number of copies of a chromosome or chromosome segment of interest in the genome of a gestating fetus, the method comprising:
A method for determining the number of copies of a chromosome or chromosome segment of interest in the genome of a gestating fetus, the method comprising:
Dependencies are inferred from the claim text.